Skip to main content
. 2013 Apr;29(2):519–522. doi: 10.12669/pjms.292.3089

Table-I.

Corneal neovascular invasion area among the two groups

Week 4 Week 8 Week 12 Week 24
Group A (Bevacizumab ) 12.5 9.7 10.5 9.3
Group B (Control) 14.2 18.3 19.8 26.7

P =0.03